Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4535427 | 1.00 | P2RX7 (0.54) | P2RX7IL1B | |
| SCHEMBL4528212 | 0.89 | P2RX7 (0.42) | P2RX7IL1B | |
| SCHEMBL4528078 | 0.88 | P2RX7 (0.47) | P2RX7IL1B | |
| SCHEMBL13706752 | 0.88 | P2RX7 (0.47) | P2RX7IL1B | |
| SCHEMBL4540743 | 0.87 | HTR3E (0.43) | P2RX7IL1B | |
| SCHEMBL13706855 | 0.87 | P2RX7 (0.46) | P2RX7IL1B | |
| SCHEMBL3641795 | 0.86 | P2RX7 (0.64) | P2RX7IL1B | |
| SCHEMBL3746886 | 0.86 | P2RX7 (0.64) | P2RX7IL1B | |
| SCHEMBL4527104 | 0.86 | P2RX7 (0.40) | P2RX7IL1B | |
| SCHEMBL13706802 | 0.86 | P2RX7 (0.46) | P2RX7IL1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120190680-A1 | Heteroaryl Amide Analogues | H. LUNDBECK A/S (DK) | 2012-07-26 | — | — | US | claimed |
| US-20120190680-A1 | Heteroaryl Amide Analogues | H. LUNDBECK A/S (DK) | 2012-07-26 | — | — | US | disclosed |
| US-20120190680-A1 | Heteroaryl Amide Analogues | H. LUNDBECK A/S (DK) | 2012-07-26 | — | — | US | disclosed |
| WO-2009108551-A2 | HETEROARYL AMIDE ANALOGUES | H. LUNDBECK A/S (DK) | 2009-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190680-A1 | Heteroaryl Amide Analogues | P2RX3, P2RX2, ADORA2A | P2RX7 5/4885IL1B 403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.